MEFENOXAM Trademark
Trademark Overview
On Friday, April 20, 2001, a trademark application was filed for MEFENOXAM with the United States Patent and Trademark Office. The USPTO has given the MEFENOXAM trademark a serial number of 78059540. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, April 17, 2002. This trademark is owned by Syngenta Participations AG. The MEFENOXAM trademark is filed in the Pharmaceutical Products category with the following description:
Agricultural fungicide.
General Information
| Serial Number | 78059540 |
| Word Mark | MEFENOXAM |
| Filing Date | Friday, April 20, 2001 |
| Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
| Status Date | Wednesday, April 17, 2002 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Agricultural fungicide. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 25, 2001 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Syngenta Participations AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Basel
CH |
Trademark Events
| Event Date | Event Description |
| Wednesday, April 17, 2002 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| Wednesday, August 8, 2001 | NON-FINAL ACTION MAILED |
| Wednesday, July 18, 2001 | ASSIGNED TO EXAMINER |
